Research & Development



  老鷹隊不停換人,但是沒用!   有這種感覺,劉莽很明白,自己的投籃絕對也是極不靠譜,說不定會因為變成了接近兩米的“巨人”身高帶來的肯定比以前強的力量以及現在截然不同的視覺角度直接把球扔飛……狠se手机网   看到劉莽第三罰居然空心命中!現場球迷又一次愣了,最後還是給了掌聲……伦理电影在线观看   ……   劉莽看著果然還是露出一副財迷相的美女房東,表示很無奈。伦理电影网站   剛剛似乎是要被教練換上場,說實在的,劉莽希望那個大額頭教練因為他剛才睡著了不讓他上場了,他現在完全沒理清現在是什麼情況,怎麼睡著睡著突然被叫醒了,然後就變成了要打球賽,還特麼是NBA的揭幕戰,實在是太草率了吧!

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo